Our Therapy areas
Following the science, leading innovation
In addition to our core therapeutic areas of Oncology; Respiratory, Inflammation and Autoimmunity; and Cardiovascular and Metabolic Disease, we are opportunity-driven in Infectious Disease.
Our portfolio is diverse and expanding, maximizing value across tumor types and unlocking the power of combinations. We are also optimizing anti-tumor immunity, addressing multiple major escape mechanisms and offering hope for lasting remission, and even cures.
We are introducing groundbreaking new biologics and even more targeted therapies for the most relentless conditions. Through a personalized healthcare approach, we are transforming the way that we treat diseases such as asthma and COPD, and other inflammatory and autoimmune conditions.
We are pushing the boundaries of science, creating innovative medicines that tackle multiple cardiovascular risk factors and diseases. This includes combining clinical expertise and basic research to scrutinize pathophysiologies, complications and risk factors - delivering breakthrough therapies and changing lives.
We are shaping a new era in the fight against dangerous and potentially deadly pathogens. This includes developing and deploying next-generation technologies and exploring new and innovative ways of using biologics to help prevent and treat some of the most challenging infectious diseases.
Our Biosuperiors team is among the best in industry - developing best-in-class biologics against clinically validated targets. Working across multiple disease areas, we're developing well-differentiated therapeutics in established and emerging markets that offer tangible benefits to patients.
Our scientists are pushing the boundaries of science every day to bring the best medicines to patients in need. For information pertaining to biologics medicines, including prescribing information and a range of websites dedicated to providing you with product-specific information, visit AstraZeneca.
A Potent Pipeline
One of the largest, most sophisticated pipelines in the industry—focused on five crucial areas with high unmet needs and with more than 120 projects and product candidates in development.
Join us at MedImmune
Our Great Place to Work strategic initiative offers a dynamic environment that fosters collaboration and innovation. We attract top minds, and we do what it takes to nurture and build talent.